Status:
COMPLETED
Wound Infusion vs Spinal Morphine for Post-caesarean Analgesia
Lead Sponsor:
Dr Madeleine Wilwerth
Conditions:
Post Caesarean Analgesia
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The aim of this study is to compare effective analgesia with continuous wound infiltration of ropivacaine through multi-holed catheter or with morphine 100 mcg added intrathecally to spinal anesthesia...
Detailed Description
Double blind, 3 groups * Control group: Rachi 0,1 ml saline, Infusion 300ml saline * Group rachi-morphine: 0,1ml =100µg morphine/300ml saline * Group KT: 0,1 ml saline/300 ml naropin 0.2%
Eligibility Criteria
Inclusion
- Patients aged 18 years and more, ASA 1 or ASA 2, pregnant with at least 34 weeks of gestational age, admitted for a planned caesarian with a Pfannenstiel incision and having signed the informed consent form.
Exclusion
- Refusal of the patient or contra-indication to locoregional anesthesia
- Allergy to the products used
- ASA 3
- ASA 4
- Sleep apnea syndrome and/or obesity (BMI \> 35)
- Size inferior to 155cm
- existence of a language barrier
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT02264821
Start Date
February 1 2012
End Date
August 1 2014
Last Update
June 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire Brugmann
Brussels, Belgium, 1020